Please use this identifier to cite or link to this item:
Type: Artigo
Title: Development, validation of LC-MS/MS method and determination of pharmacokinetic parameters of the stroke neuroprotectant Neurounina-1 in Beagle dog plasma after intravenous administration
Author: Severino, Beatrice
Corvino, Angela
Fiorino, Ferdinando
Frecentese, Francesco
Perissutti, Elisa
Caliendo, Giuseppe
Santagada, Vincenzo
Magli, Elisa
Molinaro, Pasquale
Pignataro, Giuseppe
Annunziato, Lucio
Antunes, Natalicia J.
Rojas-Moscoso, Julio
de Freitas, Noedi L.
Mendes, Gustavo D.
De Nucci, Gilberto
Abstract: Neurounina-1 [chemical name: 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1H-benzo[e][1,4]diazepin-2(3H)-one] is a new compound provided with relevant neuroprotective effect during stroke and in neonatal hypoxia by increasing the Na+/Ca2+ exchanger (NCX) isoforms NCX1 and NCX2 activity. This study shows for the first time, the development and validation of a sensitive and selective method for analysis of neurounina-1 in beagle dog plasma by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The sample preparation consisted of extraction of the analyte and the internal standard (IS) (ropivacaine) from plasma (50 mu L) by liquid-liquid extraction using acetonitrile (100 mu L). The selected reaction monitoring mode of the positive ion was performed and the precursor to the product ion transitions of m/z 365 > 83 and m/z 275 > 126 were used to measure the derivative of neurounina-1 and ropivacaine. The chromatographic separation was achieved using a Phenomenex C18 Luna (150 mm x 4.6 mm x 5 mu m) analytical column with an isocratic mobile phase composed of methanol/acetonitrile/water (50/40/10, v/v/v) + 0.1% formic acid + 1 M ammonium formate. The method was linear over a concentration range of 1-500 ng/mL. The method was applied to evaluate the pharmacokinetics of neurounina-1 after a single intravenous administration of three different doses (0.1 mg/kg, 0.3 mg/kg, and 1 mg/kg) to beagle dogs (n = 5). The mean AUC(0-tlast) values were 26.10, 115.81, and 257.28 ng*h/mL following intravenous administration of 0.1, 0.3, and 1 mg/kg, respectively. Linear pharmacokinetics was observed up to 1.0 mg/kg. The neurounina-1 was rapidly eliminated, with mean CL values of 46.24, 47.57, and 69.15 L/h, Vd of 130.31, 154.15, and 210.79 L and t(1/2) of 2.14, 2.54, and 2.04 h after intravenous administration of 0.1, 0.3, and 1 mg/kg, respectively. This new analytical method allows the rapid determination of the neurounina-1, a new developed compound, able to exert a remarkable neuroprotective effect in the low nanomolar range
Subject: Farmacocinética
Country: Suiça
Editor: Frontiers Research Foundation
Rights: Aberto
Identifier DOI: 10.3389/fphar.2019.00432
Date Issue: 2019
Appears in Collections:FCM - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.